dronabinol has been researched along with Nervous System Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bisogno, T; Cristino, L; Di Marzo, V | 1 |
| Karakayali, O; Utku, U; Uzuner, N; Yilmaz, S | 1 |
| Cameron, M; Rice, J | 1 |
| Florek, E; Piekoszewski, W; Tkaczyk, M | 1 |
| Cimander, KF; Emrich, HM; Müller-Vahl, KR; Schlimme, J; Schneider, U; Seifert, J | 1 |
| Bugaj, B; Cabała, K; Pypno, D; Waracki, M; Zdrojewicz, Z | 1 |
| Chen, DJ; Gao, FF; Gao, M; Su, QX; Wu, J | 1 |
| Minkkilä, A; Nevalainen, T; Saario, S | 1 |
| Cancro, R; Harvey, DJ; Nahas, G; Sutin, K; Turndorf, H | 1 |
| Aram, J; House, H; Makela, P; Robson, P; Wade, DT | 1 |
| Bari, M; Battista, N; Fezza, F; Gasperi, V; Maccarrone, M | 1 |
| Barenholz, Y; Biegon, A; Brewster, ME; Korablyov, V; Mechoulam, R; Nadler, V; Pop, E; Soti, F | 1 |
| Eisen, A; Feigenbaum, JJ; Mechoulam, R; Seltzer, Z; Zeltser, R | 1 |
| Scallet, AC | 1 |
| Ali, SF; Bailey, JR; Paule, MG; Scallet, AC; Slikker, W | 1 |
10 review(s) available for dronabinol and Nervous System Disorders
| Article | Year |
|---|---|
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Humans; Nervous System Diseases; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Nervous System Diseases; Treatment Outcome | 2018 |
[Marihuana and cannobinoids as medicaments].
Topics: Arthritis, Rheumatoid; Cannabidiol; Cannabinoids; Cannabis; Contraindications; Dronabinol; Drug Combinations; Humans; Inflammatory Bowel Diseases; Multiple Sclerosis; Muscle Spasticity; Nausea; Nervous System Diseases; Pain; Plant Extracts; Vomiting | 2012 |
[Dronabinol in neuropsychiatric diseases].
Topics: Alzheimer Disease; Analgesics, Non-Narcotic; Dronabinol; Humans; Nervous System Diseases; Neurologic Examination; Neuromuscular Diseases; Phytotherapy; Plant Extracts; Treatment Outcome | 2004 |
[Potential applications of marijuana and cannabinoids in medicine].
Topics: Cannabinoids; Diabetes Mellitus; Dronabinol; Humans; Medical Marijuana; Neoplasms; Nervous System Diseases; Pain; Phytotherapy; Receptors, Cannabinoid; Vomiting | 2014 |
Brain cannabinoid receptor 2: expression, function and modulation.
Topics: Animals; Brain; Cannabinoid Receptor Agonists; Dronabinol; Humans; Mental Disorders; Nervous System Diseases; Receptor, Cannabinoid, CB2 | 2017 |
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Topics: Amidohydrolases; Arachidonic Acids; Cannabinoid Receptor Modulators; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Glycerides; Humans; Monoacylglycerol Lipases; Nervous System Diseases | 2010 |
A molecular basis of the therapeutic and psychoactive properties of cannabis (delta9-tetrahydrocannabinol).
Topics: Animals; Cannabinoids; Dronabinol; Humans; Nervous System Diseases; Psychotropic Drugs; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction | 2002 |
New insights into endocannabinoid degradation and its therapeutic potential.
Topics: Arachidonic Acid; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Cannabis; Cell Membrane; Chemistry, Pharmaceutical; Dronabinol; Endocannabinoids; Glycerides; Humans; Lipoprotein Lipase; Monoacylglycerol Lipases; Neoplasms; Nervous System Diseases; Phosphatidylethanolamines; Phospholipase D; Polyunsaturated Alkamides | 2006 |
Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals.
Topics: Animals; Cannabis; Dronabinol; Nervous System Diseases | 1991 |
1 trial(s) available for dronabinol and Nervous System Disorders
| Article | Year |
|---|---|
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Hypotension; Muscle Spasticity; Nervous System Diseases; Pain; Phytotherapy; Placebos; Plant Preparations; Severity of Illness Index; Spasm; Urination Disorders | 2003 |
5 other study(ies) available for dronabinol and Nervous System Disorders
| Article | Year |
|---|---|
Neurological Symptoms and Evaluation of Cerebral Blood Flow Changes with Synthetic Cannabinoids Use.
Topics: Adult; Blood Flow Velocity; Cannabinoid Receptor Agonists; Cerebrovascular Circulation; Dronabinol; Female; Follow-Up Studies; Humans; Male; Middle Cerebral Artery; Nervous System Diseases; Retrospective Studies; Ultrasonography, Doppler, Transcranial | 2019 |
Inadvertent ingestion of marijuana - Los Angeles, California, 2009.
Topics: Adult; Cannabis; Dronabinol; Female; Food Contamination; Humans; Los Angeles; Male; Nervous System Diseases; Poisoning; Young Adult | 2009 |
Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility.
Topics: Animals; Binding, Competitive; Cells, Cultured; Dizocilpine Maleate; Dogs; Dronabinol; Drug Stability; Excitatory Amino Acid Antagonists; Humans; Hydrolysis; Morpholines; Nervous System Diseases; Neurons; Neuroprotective Agents; Piperazines; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Solubility; Structure-Activity Relationship; Tritium; Water | 1996 |
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties.
Topics: Animals; Behavior, Animal; Body Weight; Copper; Dronabinol; Drug Interactions; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nervous System Diseases; Pain; Pain Measurement; Rats; Receptors, N-Methyl-D-Aspartate | 1991 |
Chronic marijuana smoke exposure in the rhesus monkey. I. Plasma cannabinoid and blood carboxyhemoglobin concentrations and clinical chemistry parameters.
Topics: Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Chemical Analysis; Body Weight; Cannabinoids; Carboxyhemoglobin; Conditioning, Operant; Dronabinol; gamma-Glutamyltransferase; Leukocyte Count; Macaca mulatta; Male; Marijuana Smoking; Nervous System Diseases; Neutrophils | 1991 |